Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.
about
Polymer therapeutics in surgery: the next frontierBrain delivery of proteins via their fatty acid and block copolymer modificationsAgile delivery of protein therapeutics to CNSA randomized guinea pig study on external cell growth factors after fractional ultrapulsed CO(2) laser therapy.Protein-polymer conjugation-moving beyond PEGylation.Increased cutaneous wound healing effect of biodegradable liposomes containing madecassoside: preparation optimization, in vitro dermal permeation, and in vivo bioevaluationMolecules that modulate Apaf-1 activity.Polymer-drug conjugates for novel molecular targets.The enhanced permeability retention effect: a new paradigm for drug targeting in infection.Bioresponsive hydrogels.Growth factor conjugation: strategies and applications.Carbohydrate nanocarriers in biomedical applications: functionalization and construction.Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century.Preparation of hydrogel embedded polymer-growth factor conjugated nanoparticles as a diabetic wound dressing.Degradable PEGylated Protein Conjugates Utilizing RAFT Polymerization.A fibrin gel loaded with chitosan nanoparticles for local delivery of rhEGF: preparation and in vitro release studies.Decellularized scaffolds containing hyaluronic acid and EGF for promoting the recovery of skin wounds.Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation.pH-Responsive Polyacetal-Protein Conjugates Designed for Polymer Masked-Unmasked Protein Therapy (PUMPT).HPMA copolymer-phospholipase C and dextrin-phospholipase A2 as model triggers for polymer enzyme liposome therapy (PELT).Drug delivery systems and materials for wound healing applications.
P2860
Q28067866-770B18C5-1B4D-4E35-B2C3-ABB60098F0E5Q30354932-5A3D279F-AC17-43C3-8AA7-7827FF55F88FQ34079647-72B27F3E-7228-41D9-98FA-35707F0C57FCQ34610069-19C9B3D2-D0A1-490C-ADFA-2200FA6887E9Q36220152-83232FCD-26D9-404A-9385-EA7B7FC38C66Q37130296-91F446E6-D318-42D9-BCF5-8B17A8B25CB7Q37680800-17A44847-59D0-4C91-8C7D-D0194CE6D7C1Q37782076-3503292A-663A-4DB7-8CB9-764F81201729Q38051263-1B42F9B0-1E0B-44B5-9C48-A73887405EA7Q38066812-CCDA1907-73DB-4DD9-AD5D-EE1E0544DFFCQ38204731-CDFCCABD-E443-46B0-A566-519C91E1FAA6Q38567851-228EAAD8-8A02-4861-908F-C192D13BAAC4Q38645927-912B8D0B-8ADC-43CD-BDB9-F445490B38E3Q38842508-C132CD17-7C8E-4379-AFBA-FD1D68C04188Q40115426-87C6346B-8A56-458A-9415-C7DDA2E9231EQ42812501-3B61E45D-B941-4E6A-BD67-23F06E56AD71Q42831171-7EC30016-218C-422B-A3D3-E8B6068FA7E1Q47102857-FA925193-0C58-4516-8E19-D09AEF28FF0EQ47324190-68060CA2-4471-40FC-84DE-8F5AB7C6E808Q50879676-F59775CF-2C0B-460D-B60C-61C227E5B74FQ52601406-B3BF4C01-E821-48BB-9550-B901B26C317A
P2860
Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.
@en
Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.
@nl
type
label
Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.
@en
Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.
@nl
prefLabel
Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.
@en
Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.
@nl
P2093
P1476
Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair
@en
P2093
Joseph Hardwicke
Phil Stephens
Ruth Duncan
Ryan Moseley
P304
P356
10.1016/J.JCONREL.2008.07.023
P407
P577
2008-07-22T00:00:00Z